Zane Kalniņa (Zane Kalnina)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

African American

Inflammatory Response

Dendritic Cells

Staphylococcus Aureus

Top Venues

Molecular biotechnology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Zane Kalniņa, Ilva Liekniņa, Vendija Skeltona, Ināra Akopjana, Andris Kazāks, Kaspars Tārs
Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System. Molecular biotechnology 66 (5) (2024)
Zane Kalniņa, Ilva Liekniņa, Vendija Skeltona, Ināra Akopjana, Andris Kazāks, Kaspars Tārs
Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System. Molecular biotechnology (2024)
Zane Kalniņa, Ilva Liekniņa, Vendija Skeltona, Ināra Akopjana, Andris Kazāks, Kaspars Tārs
Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System. Molecular biotechnology 66 (5) (2024)
Kristine Vaivode, Irina Verhovcova, Dace Skrastina, Ramona Petrovska, Madara Kreismane, Daira Lapse, Zane Kalniņa, Kristine Salmina, Diana Rubene, Dace Pjanova
Bacteriophage-Derived Double-Stranded RNA Exerts Anti-SARS-CoV-2 Activity In Vitro and in Golden Syrian Hamsters In Vivo. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)